Accili D, Frapier C, Mosthaf L, McKeon C, Elbein S C, Permutt M A, Ramos E, Lander E, Ullrich A, Taylor S I
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
EMBO J. 1989 Sep;8(9):2509-17. doi: 10.1002/j.1460-2075.1989.tb08388.x.
Insulin binds to a receptor on the cell surface, thereby triggering a biological response within the target cell. Mutations in the insulin receptor gene can render the cell resistant to the biological action of insulin. We have studied a family in which two sisters have a genetic form of insulin-resistant diabetes mellitus. The technique of homozygosity mapping has been used to demonstrate that the mutation causing diabetes in this consanguineous family is genetically linked to the insulin receptor gene. The two insulin-resistant sisters are homozygous for a mutation encoding substitution of valine for phenylalanine at position 382 in the alpha-subunit of the insulin receptor. Transfection of mutant insulin receptor cDNA into NIH3T3 cells demonstrated that the Val382 mutation impaired post-translational processing and retarded transport of the insulin receptor to the plasma membrane. Thus, the mutation causes insulin resistance by decreasing the number of insulin receptors on the surface of the patients' cells.
胰岛素与细胞表面的受体结合,从而在靶细胞内引发生物学反应。胰岛素受体基因的突变可使细胞对胰岛素的生物学作用产生抗性。我们研究了一个家族,其中两姐妹患有遗传性胰岛素抵抗型糖尿病。纯合性定位技术已被用于证明,在这个近亲家族中导致糖尿病的突变在基因上与胰岛素受体基因相关联。这两名胰岛素抵抗型姐妹在胰岛素受体α亚基第382位氨基酸处存在编码苯丙氨酸被缬氨酸替代的突变,且为纯合子。将突变的胰岛素受体cDNA转染到NIH3T3细胞中表明,Val382突变损害了翻译后加工过程,并阻碍了胰岛素受体向质膜的转运。因此,该突变通过减少患者细胞表面胰岛素受体的数量导致胰岛素抵抗。